Gainplan LLC Bio Path Holdings Inc Transaction History

Gainplan LLC

  • $218 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 07, 2019
SELL
$12.52 - $20.81 $125,200 - $208,100
-10,000 Closed
0 $0
Q1 2019

May 13, 2019
BUY
$1.81 - $38.86 $18,100 - $388,600
10,000 New
10,000 $204,000

About BIO-PATH HOLDINGS INC

BPTH Quotes by TradingView
  • Ticker BPTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,160,160
  • Market Cap $5.51M
  • Description
  • Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...
More about BPTH
Track This Portfolio

Track Gainplan LLC Portfolio

Follow Gainplan LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gainplan LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gainplan LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email